Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells

Cardiology (Switzerland)

Volumn 137, Issue 1, 2017, Pages 43-53

  Zhao, Lin ^a   Luo, Hui ^a   Li, Xiaohui ^b   Li, Tangzhiming ^a   He, Jingni ^a   Qi, Qiangqiang ^a   Liu, Yuwei ^a   Yu, Zaixin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Exosomes; Extracellular vesicles; Pulmonary artery endothelial cells; Pulmonary artery smooth muscle cells; Pulmonary hypertension; Pulmonary vascular remodeling

Indexed keywords

HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; 3,3' (1,4 PHENYLENE)BIS[N [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ACRYLAMIDE]; ANILINE DERIVATIVE; BENZYLIDENE DERIVATIVE; CASP3 PROTEIN, HUMAN; CASPASE 3;

AORTIC ENDOTHELIAL CELL; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL SIGNALING ASSAY; CONTROLLED STUDY; EXOSOME; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INFLAMMATION; LOBECTOMY; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SMOOTH MUSCLE CELL; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; METABOLISM; PULMONARY ARTERY;

ANILINE COMPOUNDS; APOPTOSIS; BENZYLIDENE COMPOUNDS; CASPASE 3; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; EXOSOMES; HUMANS; HYPERTENSION, PULMONARY; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY;

EID: 85009423895     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000453544     Document Type: Article

References (35)

1. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F: Mechanisms of disease: Pulmonary arterial hypertension. Nat Rev Cardiol 2011; 8:443-455.
2. Shimoda LA, Laurie SS: Vascular remodeling in pulmonary hypertension. J Mol Med (Berlin) 2013; 91: 297-309.
3. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR: Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014; 115: 165-175.
4. Raposo G, Stoorvogel W: Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200: 373-383.
5. Deng L, Blanco FJ, Stevens H, Lu R, Caudrillier A, McBride M, McClure JD, Grant J, Thomas M, Frid M, Stenmark K, White K, Seto AG, Morrell NW, Bradshaw AC, MacLean MR, Baker AH: MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial Hypertension. Circ Res 2015; 117: 870-883.
6. Liu ML, Williams KJ: Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes 2012; 19: 121-127.
7. Wang X, Huang W, Liu G, Cai W, Millard RW, Wang Y, Chang J, Peng T, Fan G: Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol 2014; 74: 139-150.
8. Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Goldberg LR, Baird GL, Ventetuolo CE, Quesenberry PJ, Klinger JR: Exosomes induce and reverse monocrotalineinduced pulmonary hypertension in mice. Cardiovasc Res 2016; 110: 319-330.
9. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, Sdrimas K, Fernandez-Gonzalez A, Kourembanas S: Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012;126: 2601-2611.
10. Growcott EJ, Spink KG, Ren X, Afzal S, Banner KH: Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells. Respir Res 2006; 7: 9.
11. Labrousse-Arias D, Castillo-Gonzalez R, Rogers NM, Torres-Capelli M, Barreira B, Aragones J, Cogolludo A, Isenberg JS, Calzada MJ: HIF-2?-mediated induction of pulmonary thrombospondin-1 contributes to hypoxiadriven vascular remodelling and vasoconstriction. Cardiovasc Res 2015; 109: 115-130.
12. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJG, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S: Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012; 14: 249-256.
13. Kapustin AN, Chatrou MLL, Drozdov I, Zheng Y, Davidson SM, Soong D, Furmanik M, Sanchis P, De Rosales RTM, Alvarez-Hernandez D, Shroff R, Yin X, Muller K, Skepper JN, Mayr M, Reutelingsperger CP, Chester A, Bertazzo S, Schurgers LJ, Shanahan CM: Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 2015; 116: 1312-1323.
14. Lyu L, Wang H, Li B, Qin Q, Qi L, Nagarkatti M, Nagarkatti P, Janicki JS, Wang XL, Cui T: A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes. J Mol Cell Cardiol 2015; 89: 268-279.
15. Thery C, Amigorena S, Raposo G, Clayton A: Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006, unit 3.22.
16. Gabrielli LA, Castro PF, Godoy I, Mellado R, Bourge RC, Alcaino H, Chiong M, Greig D, Verdejo HE, Navarro M: Systemic oxidative stress and endothelial dysfunction is associated with an attenuated acute vascular response to inhaled prostanoid in pulmonary artery hypertension patients. J Card Fail 2011; 17;1012-1017.
17. Muzaffar S: Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation 2004; 110: 1140-1147.
18. Gupta MP, Evanoff V, Hart CM: Nitric oxide attenuates hydrogen peroxide-mediated injury to porcine pulmonary artery endothelial cells. Am J Physiol 1997; 272:L1133-L1141.
19. Raval Z, Losordo DW: Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 2013; 112: 1288-1302.
20. Nolte-'t Hoen EN, Buschow SI, Anderton SM, Stoorvogel W, Wauben MH: Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 2009; 113: 1977-1981.
21. King HW, Michael MZ, Gleadle JM: Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 2012; 12: 421.
22. Nogueira-Ferreira R, Ferreira R, Henriques-Coelho T: Cellular interplay in pulmonary arterial hypertension: implications for new therapies. Biochim Biophys Acta 2014; 1843: 885-893.
23. Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Goldberg LR, Baird GL, Ventetuolo CE, Quesenberry PJ, Klinger JR: Exosomes induce and reverse monocrotalineinduced pulmonary hypertension in mice. Cardiovasc Res 2016; 110: 319-330.
24. Koritzinsky EH, Street JM, Star RA, Yuen PST: Quantification of exosomes. J Cell Physiol 2016, Epub ahead of print.
25. Amabile N, Heiss C, Real WM, Minasi P, Mc-Glothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y: Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008; 177: 1268-1275.
26. Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC: Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. Am J Respir Crit Care Med 2010; 182: 261-268.
27. Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A, Zupan M, Canuet M, Grunebaum L, Brunette A: Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 177: 536-543.
28. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y: Increased CD62e + endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 2009; 28: 1081-1086.
29. Bienertova-Vasku J, Novak J, Vasku A: MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment. J Am Soc Hypertens 2015; 9:221-234.
30. Grant JS, White K, Maclean MR, Baker AH: MicroRNAs in pulmonary arterial remodeling. Cell Mol Life Sci 2013; 70: 4479-4494.
31. Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Goldberg LR, Baird GL, Ventetuolo CE, Quesenberry PJ, Klinger JR: Exosomes induce and reverse monocrotalineinduced pulmonary hypertension in mice. Cardiovasc Res 2016; 110: 319-330.
32. Zakrzewicz A, Hecker M, Marsh LM, Kwapiszewska G, Nejman B, Long L, Seeger W, Schermuly RT, Morrell NW, Morty RE: Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Circulation 2007; 115: 2957-2968.
33. Yang S, Banerjee S, Freitas AD, Cui H, Xie N, Abraham E, Liu G: miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2012; 302: 521-529.
34. Ibrahim A, Marban E: Exosomes: fundamental biology and roles in cardiovascular physiology. Annu Rev Physiol 2016; 78: 67-83.
35. Essandoh K, Yang L, Wang X, Huang W, Qin D, Hao J, Wang Y, Zingarelli B, Peng T, Fan GC: Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction. Biochim Biophys Acta 2015; 1852: 2362-2371.